Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities-Reference-Cited by-同舟云学术

Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities

Published:2020-09 Issue:9 Volume:20 Page:e597-e605
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Sallman David A.^ORCID,Barnard John^ORCID,Al Ali Najla H.,Garcia-Manero Guillermo,Sekeres Mikkael A.,DeZern Amy,Steensma David P.,Roboz Gail,Jabbour Elias,Maciejewski Jaroslaw P.,Pierce Sherry^ORCID,Padron Eric,Lancet Jeffrey E.,Kantarjian Hagop,List Alan F.,Komrokji Rami S.^ORCID

Funder

MDS Clinical Research Consortium

Edwards P. Evans Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. Chromosomal banding patterns in acute nonlymphocytic leukemia;Rowley;Blood,1976

2. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia;Bitter;Blood,1985

3. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009

4. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

5. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3; 3)(q21; q26.2) and various other 3q abnormalities in acute myeloid leukemia;Lugthart;J Clin Oncol,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome;Leukemia & Lymphoma;2024-07-04

2. Myelodysplastic Syndrome;Comprehensive Hematology and Stem Cell Research;2024

3. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);Haematologica;2023-03-23

4. Del(5q) and inv(3) in myelodysplastic syndrome: A rare case report;World Journal of Clinical Cases;2022-04-16

5. Factors affecting response to 5-azacytidine and prognosis of myelodysplastic syndrome. Is long-term survival a realistic goal?;Leukemia Research;2021-04